Senestech Inc (NASDAQ: SNES) |
|
|
|
Senestech Inc's Suppliers Performance
SNES's Supply Chain
|
SNES Costs vs Sales of Suppliers Growth |
Senestech Inc's Suppliers recorded an increase in sales by 4.54 % year on year in Q1 2025, sequentially sales grew by 0.94 %, Senestech Inc's cost of sales deteriorated by -38.57 % year on year, relative to one quarter ago cost of sales fell by -12.24 % in Q1.
•
More on SNES Suppliers
|
|
Senestech Inc's Suppliers recorded an increase in sales by 4.54 % year on year in Q1 2025, sequentially sales grew by 0.94 %, Senestech Inc's cost of sales deteriorated by -38.57 % year on year, compare to one quarter ago cost of sales fell by -12.24 % in Q1.
•
More on SNES Suppliers
Select the Relationship:
|
|
Select the Category:
|
|
Senestech Inc's Comment on Supply Chain
ContraPest contains two active ingredients, VCD, an industrial chemical, and
triptolide, a plant derived chemical from the Thunder God Vine, Tripterygium
wilfordii. ContraPest also contains several other inactive ingredients. Currently,
we source VCD from a standard industrial chemical supply provider. However,
in the near future we will be qualifying additional suppliers for VCD. Triptolide
is derived from the Thunder God Vine, which is commonly cultivated and harvested
wild in southeastern China and other Asian countries, and is available from
a variety of sources. Currently, we have one EPA registered source of purified
triptolide, and have validated a second source. However, the process to purify
triptolide for use in ContraPest is expensive, and we are seeking other, less
costly methods of triptolide production, including bio-synthetic methods. See
the discussion under the heading “Manufacturing, Marketing and Distribution”
for more information about our agreement with Bioceres and INMET to provide
research and development services to develop an efficient production method
for a bio-synthetic version of triptolide. This initiative may produce a less
expensive source of triptolide for our own use, and provide us with the potential
opportunity to earn revenue from the sale of such product to our licensees and
other potential consumers of triptolide. The inactive ingredients in ContraPest
are sourced from standard chemical supply providers.
Our manufacturing process involves the incorporation of our two active ingredients,
in low concentrations, into several inert ingredients. Once incorporated, the
entire product goes through a micro-encapsulation process in order to stabilize
the final formulation. Stabilizing the product in this manner allows it to be
delivered to rodents in a safe and effective manner. After production, the manufacturing
line is cleaned using environmentally safe methods and products.
Currently, we have production scale capability in our facilities in Arizona
to manufacture and launch ContraPest. Our internal production capabilities allow
us to meet our current and anticipated demand during 2017 for ContraPest. We
have secured equipment to double our manufacturing capacity and expect it to
be online in the third quarter of 2017. Our manufacturing process has been designed
in a modular, scalable and transportable fashion. This allows us to quickly
respond to production requirements anywhere in the world.
In addition to our domestic manufacturing facility, we have also entered into
an agreement with Bioceres and Inmet to jointly develop our manufacturing capacity
in Argentina, and intend to enter into additional manufacturing agreements in
the future on an opportunistic basis.
Senestech Inc's Comment on Supply Chain
ContraPest contains two active ingredients, VCD, an industrial chemical, and
triptolide, a plant derived chemical from the Thunder God Vine, Tripterygium
wilfordii. ContraPest also contains several other inactive ingredients. Currently,
we source VCD from a standard industrial chemical supply provider. However,
in the near future we will be qualifying additional suppliers for VCD. Triptolide
is derived from the Thunder God Vine, which is commonly cultivated and harvested
wild in southeastern China and other Asian countries, and is available from
a variety of sources. Currently, we have one EPA registered source of purified
triptolide, and have validated a second source. However, the process to purify
triptolide for use in ContraPest is expensive, and we are seeking other, less
costly methods of triptolide production, including bio-synthetic methods. See
the discussion under the heading “Manufacturing, Marketing and Distribution”
for more information about our agreement with Bioceres and INMET to provide
research and development services to develop an efficient production method
for a bio-synthetic version of triptolide. This initiative may produce a less
expensive source of triptolide for our own use, and provide us with the potential
opportunity to earn revenue from the sale of such product to our licensees and
other potential consumers of triptolide. The inactive ingredients in ContraPest
are sourced from standard chemical supply providers.
Our manufacturing process involves the incorporation of our two active ingredients,
in low concentrations, into several inert ingredients. Once incorporated, the
entire product goes through a micro-encapsulation process in order to stabilize
the final formulation. Stabilizing the product in this manner allows it to be
delivered to rodents in a safe and effective manner. After production, the manufacturing
line is cleaned using environmentally safe methods and products.
Currently, we have production scale capability in our facilities in Arizona
to manufacture and launch ContraPest. Our internal production capabilities allow
us to meet our current and anticipated demand during 2017 for ContraPest. We
have secured equipment to double our manufacturing capacity and expect it to
be online in the third quarter of 2017. Our manufacturing process has been designed
in a modular, scalable and transportable fashion. This allows us to quickly
respond to production requirements anywhere in the world.
In addition to our domestic manufacturing facility, we have also entered into
an agreement with Bioceres and Inmet to jointly develop our manufacturing capacity
in Argentina, and intend to enter into additional manufacturing agreements in
the future on an opportunistic basis.
SNES's Suppliers recorded a net loss |
Suppliers recorded net loss |
|
|
SNES's Suppliers recorded a net loss |
Suppliers recorded net loss |
SNES's vs. Suppliers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
Senestech Inc
|
3.77 |
1.93 |
-6.02 |
23 |
Becton Dickinson And Company
|
50,275.96 |
20,867.00 |
1,498.00 |
74,000 |
Among Senestech Inc suppliers, the revenue of Becton Dickinson And Company has shown a strong correlation over the past 2 years. The correlation coefficient is 0.815 |
Dupont De Nemours Inc
|
29,043.90 |
12,521.00 |
-41.00 |
24,000 |
Dupont De Nemours Inc 's revenue correlates notably with that of Senestech Inc . The correlation coefficient is 0.546 |
Codexis inc
|
173.09 |
59.35 |
-65.28 |
133 |
The revenue of Codexis inc does not correlate significantly with that of Senestech Inc . The correlation coefficient is 0.123 |
SUBTOTAL |
79,492.95 |
33,447.35 |
1,391.72 |
98,133 |
News about
Senestech Inc Contracts
|
|